Evolutionary Profile of Graves’ Disease in Children at Albert Royer National Children Hospital in Dakar

• 作者: Abou Ba Aliou Abdoulaye Ndongo Aliou Thiongane Amadou Lamine Fall Amadou Sow Aminata Mbaye Babacar Niang Dienaba Fafa Cissé Djibril Boiro Fatou Ly Idrissa Demba Ba Indou Dème Ly Lamine Thiam Ousmane Ndiaye Papa Matar Faye Yaay Joor Dieng Younoussa Keita
• 来源期刊: 儿科学期刊(英文)
• 学科: 医学
• 关键词: Graves’ Disease Child Antithyroid Drug REMISSION Senegal
• 年，卷（期）: 2019,（2）
• 页码范围: 119-125
• 页数: 7页
• 分类号: R73

摘要

Graves’ disease is the most common cause of hyperthyroidism. Adequate management is an area of controversy, especially when it comes to children. The objective of our study was to assess the outcome of Graves’ disease treatment in Albert Royer Children Hospital of Dakar. This was a retrospective study conducted from 2001 to 2015, and which involved all children between 0 to 15 years of age who were being monitored in the Albert Royer National Children Hospital. The evolutionary modalities were: stability, remission, failure, relapse, lost to follow-up and death. The data were analyzed with SPSS software version 20.0. For the comparisons, the KHI 2 or Fisher test was used with a significance threshold (p < 0.05). During the study period, 88 children were enrolled. The average age was 8.6 years [ranging from 8 months to 15 years]. The consultation delay was 11.36 months. In our study, 61.4% of the patients were regular in the follow-up, the observance was good in 40.9% of the cases and 19 patients (21.6%) were lost to follow-up. Clinical courses of 69 children after treatment with Carbimazole for 37 months were promising in 21 cases (30.43%), with 17 cases of remission (24.63%) and 4 cases of stability (5.8%). Age older than 10, the initial ATD dose greater than 1 mg/kg/day and the initial free T4 lower than 50 pmol/l were significantly associated with remission with a p value of 0.01;0.024 and 0.004.